WELCOME TO STRAMSEN BIOTECH, INC.
Science Knows No Boundaries. We Are Exploring The Wonders of Science.
![]() | ![]() | ![]() | ![]() |
---|---|---|---|
![]() | ![]() |
We are heavily focused on developing Medicines for infectious and noninfectious diseases.
At Stramsen Biotech Inc., our mission is resolute: to revolutionize patient care with safer, more effective treatments. By leveraging the power of nature, we're pioneering plant-based medicines that not only rival traditional pharmaceuticals but often surpass them in terms of safety profiles and reduced side effects. This innovative approach positions us to become a household name in the pharmaceutical industry, transforming the landscape of modern medicine.
Our competitive edge lies in our proprietary, extensive medicinal plant database, a treasure trove of botanical knowledge accessible to our world-class team of scientists. This invaluable resource fuels our robust pipeline of 33 drug candidates at various stages of development. Among these, 11 promising medicines are currently in early-stage clinical trials, demonstrating our commitment to rigorous scientific validation. Some of these groundbreaking treatments are already improving lives in international markets, showcasing our global impact and underscoring our potential for widespread transformation in healthcare.
At Stramsen Biotech, we're not just developing drugs; we're cultivating a new paradigm in pharmaceutical innovation. Our plant-based approach offers a unique value proposition: effective treatments that work in harmony with the human body, potentially reducing the burden of side effects that often accompany synthetic medicines. This patient-centric focus not only addresses unmet medical needs but also aligns with the growing global trend towards natural, sustainable solutions in healthcare.
Stramsen Biotech's strength lies in our extensive medicinal plant database, accessible to our world-class scientists. This invaluable resource fuels our robust pipeline of 33 drug candidates at various stages of development, including 11 promising medicines in early-stage clinical trials. Some of these groundbreaking treatments are already improving lives overseas, showcasing our global impact and potential.
Our focus spans a wide range of critical health concerns, including:
-
Various types of cancer
-
Cardiovascular diseases
-
HIV
-
Wound healing
-
Kidney diseases
-
Diabetes
-
Arthritis
-
Neurological disorders
It's worth noting that approximately 40% of medicines prescribed worldwide are derived from medicinal plants. At Stramsen Biotech, we're not just following this trend - we're leading it. Our rigorous clinical trials ensure that we're delivering treatments that are both innovative and reliable.
1. SBX 1052 - Controls/prevents enlargement of the prostate glands.
2. SBX1968 - Controls/prevents the proliferation and metastasis prostate glands cancer.
3. SBX 2021 - Controls/prevents the proliferation and metastasis of various cancer cells.
4. SBX 2022 - Controls/prevents the proliferation and metastasis of blood cancer.
5. SBX 2023 - treats various forms of peripheral neuropathic disorders
6. SBX 2000 - for management of various forms of cardiovascular diseases
7. SBX 1977 – A wound healing drug with cell proliferation and strong antibacterial properties.
8. SBX 2048 - Controls HIV and improves immunity
9. SBX1988 – Controls diabetes
10. SBX2011 - Treats kidney infections and dissolves / breaks-up gallstones.
11. SBX1967 – Relieves bone/joint pains, treats bone/joint infection improves joint lubrication.